Protara Therapeutics, Inc. (TARA) Financials

TARA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 191.9 million 10.7 million
Dec. 31, 2025 209.5 million 13.1 million
Sept. 30, 2025 144.6 million 12.3 million
June 30, 2025 156.9 million 12.5 million

TARA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -21.3 million 1.4 million
Dec. 31, 2025 -17.0 million 1.0 million
Sept. 30, 2025 -12.5 million 1.0 million
June 30, 2025 -12.3 million 903000

TARA Net Income

No data available :(

TARA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 135.8 million 1.8 million 3.1 million
Dec. 31, 2025 155.6 million - 2.1 million
Sept. 30, 2025 132.7 million - 3.7 million
June 30, 2025 122.2 million - 3.9 million

TARA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 42.8 million
Dec. 31, 2025 46.0 million
Sept. 30, 2025 42.3 million
June 30, 2025 42.3 million

TARA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 13.5 million 6.1 million -
Dec. 31, 2025 24000 13.1 million 6.0 million -
Sept. 30, 2025 4000 9.6 million 5.2 million -
June 30, 2025 22000 10.8 million 5.8 million -

TARA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 90000
Dec. 31, 2025 - 93000
Sept. 30, 2025 - 88000
June 30, 2025 - 98000

TARA

Price: $3.81

52 week price:
2.77
7.82

Earnings Per Share: -1.36 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 2909

Market Capitalization: 160.5 million

Links: